Clinical trial
Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals
Opening soon · Not applicable · 1 countries · Registry ID NCT07423884
What this study is about
This study aims to investigate the effect of a low-calorie diet rich in medium-chain triglycerides (MCTs) based on traditional Minangkabau foods on metabolic biomarkers in individuals with obesity. The traditional Minangkabau foods used in this study consist primarily of coconut milk-based dishes, which contain coconut oil as a natural source of MCTs. The metabolic biomarkers assessed include body mass index (BMI), waist circumference, systolic and diastolic blood pressure, body fat percentage, fasting blood glucose levels, lipid profile, leptin concentrations, and DNA methylation of the leptin gene promoter. Based on these metabolic biomarker measurements, participants will be classified into metabolic obesity phenotypes, namely metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO). The researchers hypothesize that the provision of a low-calorie, MCT-rich diet based on traditional Minangkabau foods will have a significant effect on metabolic biomarkers and metabolic status in individuals with obesity.
Basic eligibility
Full registry criteria
Treatments and study arms
Low-Calorie Diet Rich in Medium-Chain Triglycerides (MCTs) Based on Traditional Minangkabau Foods
Participants in the intervention group received a nutritionally balanced low-calorie diet rich in medium-chain triglycerides (MCTs) derived from traditional Minangkabau foods. The dietary intervention was designed to provide an energy deficit of 500-600 kcal compared with participants' habitual daily intake. Assessments were conducted before and after the intervention period.
Primary outcomes
BMI is calculated as body weight in kilograms divided by the square of height in meters (kg/m²).
Waist circumference is measured around the abdomen at the level of the umbilicus.
Body fat percentage is assessed using bioelectrical impedance analysis (BIA).
Blood pressure is measured using a digital tensimeter.
Fasting blood glucose levels are measured using a clinical chemistry analyzer.
The lipid profile includes total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol. Measurements are performed using a clinical chemistry analyzer (photometer).
Serum leptin concentrations are measured using appropriate laboratory methods (ELISA).
DNA methylation status of the leptin gene promoter is assessed using MSP (Methylation-Specific PCR).
Study locations
1 locations were listed when this page was built. The first 40 are shown.